EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Uses and limitations of artificial intelligence for oncology

Likhitha Kolla, Ravi B Parikh iD

Cancer · 15.06.2024 · 130 (12) · 2101-2107

DOI: 10.1002/cncr.35307 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer, online erschienen am 30.03.2024. Verfasst von Likhitha Kolla und 1 weiteren Autor:innen. Beteiligte Einrichtung: Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Artificial Intelligence, Medical Oncology, Neoplasms. Die Arbeit wurde bisher 135-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NLM NIH HHS, NCI NIH HHS, US National Library of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Modern artificial intelligence (AI) tools built on high‐dimensional patient data are reshaping oncology care, helping to improve goal‐concordant care, decrease cancer mortality rates, and increase workflow efficiency and scope of care. However, data‐related concerns and human biases that seep into algorithms during development and post‐deployment phases affect performance in real‐world settings, limiting the utility and safety of AI technology in oncology clinics. To this end, the authors review the current potential and limitations of predictive AI for cancer diagnosis and prognostication as well as of generative AI, specifically modern chatbots, which interfaces with patients and clinicians. They conclude the review with a discussion on ongoing challenges and regulatory opportunities in the field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceMedical OncologyNeoplasmsHumansAlgorithmsPrognosis

Stichwörter der Autor:innen

algorithmic fairnessartificial intelligenceexplainabilitymachine learningoncologypredictive analyticsradiomics

Autor:innen und Institutionen

  • Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Ravi B Parikh

Förderung

  • NLM NIH HHS
  • NCI NIH HHS
  • US National Library of Medicine

Zitieren

APA

Kolla, L., & Parikh, R. B. (2024). Uses and limitations of artificial intelligence for oncology. Cancer, 130(12), 2101-2107. https://doi.org/10.1002/cncr.35307

Vancouver

Kolla L, Parikh RB. Uses and limitations of artificial intelligence for oncology. Cancer. 2024;130(12):2101-2107. doi:10.1002/cncr.35307

BibTeX
@article{Kolla2024,
  author = {Kolla, Likhitha and Parikh, Ravi B},
  title = {Uses and limitations of artificial intelligence for oncology},
  journal = {Cancer},
  year = {2024},
  volume = {130},
  number = {12},
  pages = {2101--2107},
  doi = {10.1002/cncr.35307}
}
Kostenlos starten →